AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PRO MEDICUS LTD

234.270

+4.8602.12%

Volume:191.40K

Turnover:44.78M

Market Cap:24.47B

PE:249.38

High:236.470

Open:232.000

Low:231.370

Close:229.410

Loading ...

Overview Company News Filings

Pro Medicus Buys Back AU$6.4 Million Worth of Shares

MT Newswires Live

New to investing in ASX shares? Here's what I wish I knew when I started

Pro Medicus to buyback 10.4 million shares. What does this mean?

Top brokers name 3 ASX shares to buy next week

How investing $50 a week into ASX shares could make you a millionaire

One likely reason the market has soured on Pro Medicus

Why Block, Corporate Travel, Incitec Pivot, and Pro Medicus shares are falling today

Brokers name 3 ASX shares to buy today

Why this amazing ASX 200 tech stock could rise 30%+

ASX Market Close: Reject Shop rockets ~ 110% after Canadian offer | March 27, 2025

The Market Herald

Pro Medicus shares drop 7%: falling knife or buying opportunity?

Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today

Pro Medicus Looks Fairly Valued Post Sell-off -- Market Talk

Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Near-Term Growth Forecasts

Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Down Near-Term Growth Forecasts

BUZZ-Jefferies adjusts down Australia's Pro Medicus' near-term growth forecasts

Top brokers name 3 ASX shares to buy today

Pro Medicus shares up 255% in 2 years! Will the bubble burst?

Morgans Financial Upgrades Pro Medicus to Add from Hold; Price Target is AU$250

MT Newswires Live

Exploring Audinate Group And 2 Emerging Australian High Growth Tech Stocks

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PME.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PME.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","market":"AU","secType":"STK","nameCN":"PRO MEDICUS LTD","latestPrice":234.27,"timestamp":1746079920000,"preClose":229.41,"halted":0,"volume":191399,"delay":0,"nameEN":"PRO MEDICUS LTD","floatShares":52960584,"shares":104462909,"eps":0.939404,"marketStatus":"Not Yet Opened","change":4.86,"latestTime":"05-01 16:12:00 AEST","open":232,"high":236.47,"low":231.37,"amount":44776661,"amplitude":0.022231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.939404,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":229.41,"dividendRate":0.002006,"openAndCloseTimeList":[[1746057600000,1746079200000]],"volumeRatio":0.7258166052694812,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PME.AU\",,,,,undefined,":{"symbol":"PME.AU","floatShares":52960584,"roa":"32.90%","roe":"51.53%","lyrEps":0.792737,"volumeRatio":0.7258166052694812,"shares":104462909,"dividePrice":0.47,"high":236.47,"amplitude":0.022231,"preClose":229.41,"low":231.37,"week52Low":109.96,"pbRate":"110.11","psRate":"132.58","week52High":298.706,"institutionHeld":0,"latestPrice":234.27,"eps":0.939404,"divideRate":0.002006,"volume":191399,"delay":0,"ttmEps":0.939404,"open":232,"prevYearClose":249.891,"prevWeekClose":210.78,"prevMonthClose":229.41,"prevQuarterClose":199.79,"fiveDayClose":208.68,"twentyDayClose":199.79,"sixtyDayClose":269.693},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PME.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524108188","title":"Pro Medicus Buys Back AU$6.4 Million Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2524108188","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524108188?lang=en_us&edition=fundamental","pubTime":"2025-04-01 09:06","pubTimestamp":1743469582,"startTime":"0","endTime":"0","summary":"Pro Medicus  repurchased 28,326 fully paid ordinary shares in an on-market buyback for nearly AU$6.4 million, according to a Tuesday filing with the Australian bourse.The company proposes to buy back about 10.4 million shares under the program.The company's shares were down almost 1% in recent Tuesday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XAO.AU","BK7094","PME.AU","XKO.AU"],"gpt_icon":0},{"id":"2524183582","title":"New to investing in ASX shares? Here's what I wish I knew when I started","url":"https://stock-news.laohu8.com/highlight/detail?id=2524183582","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524183582?lang=en_us&edition=fundamental","pubTime":"2025-04-01 08:56","pubTimestamp":1743468960,"startTime":"0","endTime":"0","summary":"Starting your investing journey with ASX shares can feel a bit like learning a new language. There's investment jargon, there are charts, and there's someone on TV shouting about what to buy, sell, or","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/01/new-to-investing-in-asx-shares-heres-what-i-wish-i-knew-when-i-started/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["VAS.AU","BK4550","BK4585","BK7094","FDN","NDQ.AU","BK4588","PME.AU","ETF.AU"],"gpt_icon":0},{"id":"2524009379","title":"Pro Medicus to buyback 10.4 million shares. What does this mean?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524009379","media":"MotleyFool","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524009379?lang=en_us&edition=fundamental","pubTime":"2025-04-01 07:49","pubTimestamp":1743464986,"startTime":"0","endTime":"0","summary":"This morning, Pro Medicus Ltd  announced it would be buying back 10.2 million of its own shares. The buyback program is to occur between 1 April 2025 and 31 March 2026.  This comes after the once-high-flying healthcare technology stock has been heavily sold off. Pro Medicus is down around 33% from its 19 February peak.At the time of writing, the company is changing hands at $198 a share. What is a buyback?There is no doubt that Pro Medicus is one of the highest-quality businesses on the ASX.Over the past 10 years, it has grown revenue at a compound annual growth rate  of 28%, consistently winning and renewing long-dated contracts. This trajectory appears set to continue. The business is supported by many tailwinds, including an ageing population and increased diagnostic imaging usage.Pro Medicus also operates in a large addressable market, withFortune Business Insightsestimating the U.S. diagnostic imaging services market to grow from $130.38 billion in 2023 to $206.84 billion by 2030.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/01/pro-medicus-to-buyback-10-4-million-shares-what-does-this-mean/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CBA.AU","BK7094","BK7507","BK7142","STO.AU","BK7030","PME.AU","BK7135","CAGR","BK4159","QAN.AU"],"gpt_icon":0},{"id":"2523418276","title":"Top brokers name 3 ASX shares to buy next week","url":"https://stock-news.laohu8.com/highlight/detail?id=2523418276","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523418276?lang=en_us&edition=fundamental","pubTime":"2025-03-30 06:13","pubTimestamp":1743286380,"startTime":"0","endTime":"0","summary":"It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Her","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/30/top-brokers-name-3-asx-shares-to-buy-next-week-30-march-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7506","IE0004086264.USD","BK4516","BK7501","IE0034235188.USD","BK7040","BK4585","LU1868836757.USD","LU1868836591.USD","LU2750360997.AUD","IE00B19Z3581.USD","LU2237443978.SGD","IE0002270589.USD","PME.AU","LU2237443382.USD","LU1868837300.USD","WOW.AU","IE0004091025.USD","LU2471134523.USD","BK4533","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4504","BK7094","BK7511","IE00BFXG1179.USD","LU2471134952.CNY","LU1791807156.HKD","LU1668664300.SGD","GOR.AU","LU2471134796.USD","LU2750360641.GBP","BK7104","LU2237438978.USD","LU0061475181.USD","LU0106831901.USD","BK4127","LU2237443895.HKD","BK4588","LU2237443622.USD","BK4552","BK4550","LU1868836914.USD","LU2237443549.SGD","LU1868837136.USD","LU2237443465.HKD","LU0096364046.USD","LU2471134879.HKD"],"gpt_icon":0},{"id":"2523534816","title":"How investing $50 a week into ASX shares could make you a millionaire","url":"https://stock-news.laohu8.com/highlight/detail?id=2523534816","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523534816?lang=en_us&edition=fundamental","pubTime":"2025-03-29 03:34","pubTimestamp":1743190440,"startTime":"0","endTime":"0","summary":"For many young investors, the idea of building serious wealth through the share market can feel out of reach — especially when starting with just a small amount. But what if I told you that investing as little as $50 a week into ASX shares could make a meaningful difference to your financial future?If you stick with it through to age 51, your portfolio could be worth around $415,000. And by the time you reach 61, you're looking at approximately $1.1 million — all from investing $50 a week for 40 years. Why compounding works Compounding is what happens when your investments generate returns — and then those returns go on to generate their own returns. It is like a snowball rolling down a hill: it starts small, but the longer it rolls, the more momentum it gains and the large it becomes. And the best part?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/29/how-investing-50-a-week-into-asx-shares-could-make-you-a-millionaire/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7016","PME.AU","BK7094","XRO.AU","BK7503"],"gpt_icon":0},{"id":"2523687047","title":"One likely reason the market has soured on Pro Medicus","url":"https://stock-news.laohu8.com/highlight/detail?id=2523687047","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523687047?lang=en_us&edition=fundamental","pubTime":"2025-03-29 03:30","pubTimestamp":1743190200,"startTime":"0","endTime":"0","summary":"Pro Medicus Ltd  is once again trading lower, with its share price changing hands for $201.80 at market close on Friday.Having declined 23% since 3 March without any material announcements, investors may be left wondering what has transpired.Investors have likely come to terms with the fact that Pro Medicus is an expensive stock.Given the range of outcomes, it's hard to determine what Pro Medicus is really worth.With JP Morgan forecasting a 40% chance of a recession in the U.S. according toReuters, its plausible some clients may not have the funds to renew. It may be beyond Pro Medicus' control and simply come down to budget cuts.In a 'risk off' equities environment, it is usually the most expensive stocks that are punished the most. Between February 2024 and February 2025, Pro Medicus rocketed more than 200%. It's understandable that investors have taken some profits.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/29/one-likely-reason-the-market-has-soured-on-pro-medicus/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CAGR","PME.AU","BK7094","BK4159"],"gpt_icon":0},{"id":"2522564166","title":"Why Block, Corporate Travel, Incitec Pivot, and Pro Medicus shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522564166","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522564166?lang=en_us&edition=fundamental","pubTime":"2025-03-28 09:32","pubTimestamp":1743125548,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is on course to end the week with a small gain. At the time of writing, the benchmark index is up 0.3% to 7,992.8 points. Four ASX shares that have failed to follow the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/28/why-block-corporate-travel-incitec-pivot-and-pro-medicus-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","IPL.AU","XJO.AU","BK7158","BK7070","PME.AU","BK7025","XYZ.AU","CTD.AU"],"gpt_icon":0},{"id":"2522172564","title":"Brokers name 3 ASX shares to buy today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522172564","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522172564?lang=en_us&edition=fundamental","pubTime":"2025-03-28 09:04","pubTimestamp":1743123848,"startTime":"0","endTime":"0","summary":"It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summaris","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/28/brokers-name-3-asx-shares-to-buy-today-28-march-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2237443549.SGD","LU2237443465.HKD","BK7094","LU1868837300.USD","IE00BFXG1179.USD","AX1.AU","LU2750360641.GBP","BK4552","BK7021","PME.AU","BK4127","LU2750360997.AUD","LU0096364046.USD","LU2471134796.USD","BK7511","IE0034235188.USD","IE0004086264.USD","IE00B19Z3581.USD","BK7041","IE0002270589.USD","WES.AU","BK4588","LU1668664300.SGD","LU2237443622.USD","LU2471134952.CNY","LU0106831901.USD","LU2237438978.USD","LU1868836591.USD","BK4533","LU1791807156.HKD","LU2237443382.USD","BK4516","LU0061475181.USD","IE00B19Z3B42.SGD","LU2471134879.HKD","LU1868836757.USD","LU1868836914.USD","LU2237443978.SGD","BK4504","BK4550","LU2471134523.USD","LU1868837136.USD","BK7153","LU2237443895.HKD","IE0004091025.USD","IE00BSNM7G36.USD","BK4585"],"gpt_icon":0},{"id":"2522255419","title":"Why this amazing ASX 200 tech stock could rise 30%+","url":"https://stock-news.laohu8.com/highlight/detail?id=2522255419","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522255419?lang=en_us&edition=fundamental","pubTime":"2025-03-28 06:11","pubTimestamp":1743113464,"startTime":"0","endTime":"0","summary":"Pro Medicus Limited  shares took a big hit yesterday, dropping almost 8% after analysts trimmed their near term earnings estimates. This latest decline means that the ASX 200 tech stock has now fallen 30% from its record high. Is this a buying opportunity?Let's see what one leading broker is saying about the health imaging technology company. What's being said about this ASX 200 tech stock?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/28/why-this-amazing-asx-200-tech-stock-could-rise-30/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2522319667","title":"ASX Market Close: Reject Shop rockets ~ 110% after Canadian offer | March 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522319667","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522319667?lang=en_us&edition=fundamental","pubTime":"2025-03-27 13:54","pubTimestamp":1743054840,"startTime":"0","endTime":"0","summary":"The ASX200 closed down 0.38% at 7,969 points.Energy was the best performing sector, up1%, followed by Staples, up 0.4%, and Materials, up 0.33%.Real Estate was the biggest loser, down 2.2%, followed, IT, down 2%, and Discretionary, down 1%.Core Lithium  closed up 5.2% following the release of anupdateon its Finniss Lithium Operation.Neuren Pharmaceuticals  finished up 0.67% on news the company is developing a new product to treat infant injuries when a baby’s brain does not receive enough oxygen or blood flow before or shortly after birth.And, Reject Shop  has closed up 109% after investors flocked to the stock as the company received a takeover offer. Canada’s Dollarama  cut a deal to buy Reject Shop for $259 million.Domain  closed down 4.9% after CoStar Group  improved its takeover offer, from $4.20 cash per share to $4.43 per share.And, WiseTech  closed down 2% as investors reacted to Australian Super selling its entire $580M stake in the company. AusSuper’s move came due to “govern","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-reject-shop-rockets-110-after-canadian-offer-march-27-2025-2025-03-27/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7504","BK7508","LU2095319765.USD","BK4548","BK7041","IE0004445239.USD","BK7016","NEU.AU","DHG.AU","BK4585","CSGP","PME.AU","BK7002","IE0009356076.USD","BK7095","LU2210149790.SGD","BK7096","BK7503","LU0708995401.HKD","LU0672654240.SGD","BK4079","LU2210150020.SGD","BK4588","LU1267930730.SGD","BK7153","TRS.AU","LU0109391861.USD","CXO.AU","BK4123","LU0390134368.USD","BK7094","LU0320765059.SGD","WTC.AU"],"gpt_icon":0},{"id":"2522349132","title":"Pro Medicus shares drop 7%: falling knife or buying opportunity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522349132","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522349132?lang=en_us&edition=fundamental","pubTime":"2025-03-27 13:28","pubTimestamp":1743053300,"startTime":"0","endTime":"0","summary":"No-one has a crystal ball to tell what's going to happen next. Shares go up and down in price every week. There can be quite dramatic swings in a relatively short amount of time, if they react to business updates or wider economic issues. Investors seem worried about what's going on with the US' tariffs  and how that could have negative flow-on effects. Various ASX growth shares have seen declines in recent weeks. One of the main  criticisms, in my opinion, that could be said about Pro Medicus shares is that it trades on a high price/earnings (P/E) ratio. For example, even after the decline, the Pro Medicus share price is trading at 198x FY25's estimated earnings, according to Commsec. Is it a buying opportunity?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/27/pro-medicus-shares-drop-7-falling-knife-or-buying-opportunity/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4185","PACS","PME.AU","BK7094","EBIT"],"gpt_icon":0},{"id":"2522391277","title":"Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522391277","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522391277?lang=en_us&edition=fundamental","pubTime":"2025-03-27 10:56","pubTimestamp":1743044164,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is having a poor session on Thursday. In afternoon trade, the benchmark index is down 0.5% to 7,960.9 points. Four ASX shares that are falling more than most today are ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/27/why-domain-mesoblast-pro-medicus-and-tuas-shares-are-tumbling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["PME.AU","LU2210150020.SGD","BK4585","BK7503","BK4123","IE0009356076.USD","BK4548","MESO","BK7002","TUA.AU","BK7042","BK7067","MSB.AU","BK7508","XJO.AU","CSGP","DHG.AU","LU0708995401.HKD","BK7501","BK4575","LU0390134368.USD","IE0004445239.USD","BK4150","LU0672654240.SGD","MSC","LU0320765059.SGD","BK4139","LU2210149790.SGD","BK4079","BK7094","BK4588","LU2095319765.USD","LU0109391861.USD","LU1267930730.SGD"],"gpt_icon":0},{"id":"2522393280","title":"Pro Medicus Looks Fairly Valued Post Sell-off -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2522393280","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522393280?lang=en_us&edition=fundamental","pubTime":"2025-03-27 10:24","pubTimestamp":1743042240,"startTime":"0","endTime":"0","summary":"0224 GMT - Medical-imaging tech-provider Pro Medicus needs to improve the visibility of its business pipeline or demonstrate an ability to speed up market-share gains in order to turn Macquarie analysts more positive on the stock. The analysts moderate their market-share assumption to 10% in fiscal 2027, from 11% previously. They say to clients in a note that they have largely factored in the announcement of further contract wins and renewals. Pro Medicus has yet to demonstrate material uptake of opportunities in adjacent specialities, such as cardiology, they say, adding that they see the stock as fairly valued following a recent de-rate. Macquarie trims its target price by 0.4% to A$257.40, maintaining a neutral rating. Shares are down 7.6% at A$210.405. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PME.AU","POST","BK7094","BK4212"],"gpt_icon":0},{"id":"1165001079","title":"Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Near-Term Growth Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1165001079","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165001079?lang=en_us&edition=fundamental","pubTime":"2025-03-27 07:36","pubTimestamp":1743032178,"startTime":"0","endTime":"0","summary":"Shares of Pro Medicus Ltd , an Australian health imaging firm, plummeted 5.02% in Thursday's intraday trading session following Jefferies' downward revision of the company's near-term growth forecasts. The adjustment comes as a result of reassessing the impact of the Trinity contract and cardiology contribution estimates.Jefferies has trimmed Pro Medicus' cardiology contribution estimates, leading to a reduced implied market share increase projection. The brokerage now forecasts a 14% market sha","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PME.AU"],"gpt_icon":0},{"id":"1143291145","title":"Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Down Near-Term Growth Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1143291145","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143291145?lang=en_us&edition=fundamental","pubTime":"2025-03-27 07:36","pubTimestamp":1743032177,"startTime":"0","endTime":"0","summary":"Shares of Pro Medicus Ltd , an Australian health imaging firm, plummeted 5.02% in Thursday's trading session following a report from Jefferies that revised down the company's near-term growth forecasts.The brokerage firm cited the stepped minimum nature of the Trinity contract as a key factor in their decision to adjust Pro Medicus' growth projections. Jefferies also trimmed its estimates for the company's cardiology contribution, resulting in a reduction of the implied market share increase to ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Pro Medicus Plummets 5.02% as Jefferies Adjusts Down Near-Term Growth Forecasts","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PME.AU"],"gpt_icon":0},{"id":"2522302073","title":"BUZZ-Jefferies adjusts down Australia's Pro Medicus' near-term growth forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522302073","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522302073?lang=en_us&edition=fundamental","pubTime":"2025-03-27 04:12","pubTimestamp":1743019950,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies adjusts down Australia's Pro Medicus' near-term growth forecasts** Jefferies revises down health imaging firm Pro Medicus' PME.AX near-term growth forecasts, considering the stepped minimum nature of the Trinity contract** Brokerage trims firm's cardiology contribution estimates, leading to implied market share increase to 14% in FY26, down 15% from previous estimates** Despite these adjustments, brokerage maintains its A$250 price target and 'Hold' rating** Stock down 9% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3N3Q91JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","PME.AU"],"gpt_icon":0},{"id":"2522825871","title":"Top brokers name 3 ASX shares to buy today","url":"https://stock-news.laohu8.com/highlight/detail?id=2522825871","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522825871?lang=en_us&edition=fundamental","pubTime":"2025-03-26 09:20","pubTimestamp":1742952040,"startTime":"0","endTime":"0","summary":"Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week. Three ASX shares that brok","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/26/top-brokers-name-3-asx-shares-to-buy-today-26-march-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7119","PME.AU","BK7506","BRG.AU","BK7094","BK7104","GOR.AU"],"gpt_icon":0},{"id":"2522327248","title":"Pro Medicus shares up 255% in 2 years! Will the bubble burst?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522327248","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522327248?lang=en_us&edition=fundamental","pubTime":"2025-03-26 05:29","pubTimestamp":1742938182,"startTime":"0","endTime":"0","summary":"Pro Medicus Ltd  is an Australian healthcare technology company. It develops and sells radiology imaging software used in hospitals and medical imaging centres. Over the last two years Pro Medicus shares have grown by a massive 255%.  On one hand you might look at this growth and think you're too late to the party and have missed an opportunity. On the other hand, quality holdings can continue to hit record high after record high and a one or two year run could be just the beginning. Let's look at both sides of the coin. Can Pro Medicus continue to soar?Of course buying shares in a company that has skyrocketed over the last two years like Pro Medicus can be daunting. It's possible the future growth that many have predicted is already baked into its current share price, and investors have overvalued this tech stock. Its lofty price to earnings ratio of 238 could also be a red flag for some. Another option for investors who are looking to dip their toe in the water could be an ETF like B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/26/pro-medicus-shares-up-255-in-2-years-will-the-bubble-burst/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7094","PME.AU","ATEC.AU"],"gpt_icon":0},{"id":"2522012812","title":"Morgans Financial Upgrades Pro Medicus to Add from Hold; Price Target is AU$250","url":"https://stock-news.laohu8.com/highlight/detail?id=2522012812","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522012812?lang=en_us&edition=fundamental","pubTime":"2025-03-25 17:24","pubTimestamp":1742894678,"startTime":"0","endTime":"0","summary":"Pro Medicus (ASX:PME) has an average rating of hold and mean price target of AU$272.31, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PME.AU"],"gpt_icon":0},{"id":"2522704765","title":"Exploring Audinate Group And 2 Emerging Australian High Growth Tech Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2522704765","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522704765?lang=en_us&edition=fundamental","pubTime":"2025-03-25 03:05","pubTimestamp":1742843149,"startTime":"0","endTime":"0","summary":"The Australian market recently saw the ASX200 close flat at 7,936 points with mixed performance across sectors, as Discretionary and Financials led gains while Information Technology lagged behind. In this environment of fluctuating sector performance, identifying high growth tech stocks like Audinate Group and other emerging players in Australia involves looking for companies that demonstrate resilience and innovation amidst broader market challenges.Operations: The company generates revenue primarily through its Value-Added IT Reseller and IT Solutions Provider segment, which accounts for A$798.05 million. The business focuses on delivering comprehensive IT solutions and services across multiple regions, contributing to its","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-audinate-group-2-emerging-190549564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XAO.AU","BK7073","PME.AU","XJO.AU","AD8.AU","BK7061","DTL.AU","XKO.AU","BK7503","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PME.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-27","symbol":"PME.AU","amount":0.25,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-02-28","name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-02-28","currency":"AUD","dateTimestamp":1740574800000,"payDate":"2025-03-21"},{"date":"2025-02-11","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-04","symbol":"PME.AU","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-05","defaultRemindTime":1725408000000,"name":"PRO MEDICUS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-26","payableDate":"2024-09-05","currency":"AUD","dateTimestamp":1725372000000,"payDate":"2024-09-26"},{"date":"2024-08-14","symbol":"PME.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723593600000,"name":null,"time":"","dateTimestamp":1723557600000,"actualEps":null},{"date":"2024-02-29","symbol":"PME.AU","amount":0.18,"announcedDate":null,"type":"dividend","market":"AU","newRecordDate":"2024-03-01","defaultRemindTime":1709161200000,"name":"Pro Medicus Ltd","recordDate":"2024-03-22","payableDate":"2024-03-01","currency":"AUD","dateTimestamp":1709125200000,"payDate":"2024-03-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PME.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-02","value":0.06,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-19","value":0.07,"currency":"AUD"},{"executeDate":"2021-09-09","recordDate":"2021-09-10","paymentDate":"2021-10-01","value":0.08,"currency":"AUD"},{"executeDate":"2022-03-03","recordDate":"2022-03-04","paymentDate":"2022-03-25","value":0.1,"currency":"AUD"},{"executeDate":"2022-09-08","recordDate":"2022-09-09","paymentDate":"2022-09-30","value":0.12,"currency":"AUD"}]}}